Nachrichten zur Maravai LifeSciences Holdings Aktie

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript

…

Maravai (MRVI) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEMay 7, 2026CALL PARTICIPANTSChief Executive Officer — Bernd BrustChief Financial Officer — Rajesh AsarpotaChief Scientific Officer…

AIM movers: Windar Photonics hit by China delay and new licence agreement for Aptamer

Synthetic binders developer Aptamer (LON: APTA) has signed a licensing agreement with Alphazyme, a Maravai LifeSciences company that supplies speciality…

Maravai LifeSciences Holdings Inc.: CEO kauft Aktien für 1,5 Mio. USD - Langfristige Perspektive wird durch Ausweitung der mRNA-Anwendungen geprägt sein

Maravai LifeSciences Holdings Inc. (MRVI) agiert als ein Unternehmen im Life-Sciences-Sektor und bietet kritische, qualitativ hochwertige Produkte und Dienstleistungen an,…

Maravai LifeSciences Holdings, Inc. 2025 Q1 - Results - Earnings Call Presentation

…

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

…

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates

Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of -14.29% and 5.46%, respectively, for the quarter ended March 2025. Do…

MRVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – MRVI

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions and Encourages Investors to Contact the Firm

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – MRVI

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings,…

Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman

SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024…

MRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences…

Maravai LifeSciences Holdings, Inc. (MRVI) Investors: May 5, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., April 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI

NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2024.…

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript

…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skyworks Solutions, Maravai, and Manhattan Associates and Encourages Investors to Contact the Firm

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Class Action Reminder for MRVI Investors: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Securities Fraud Class Action Lawsuit

RADNOR, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Schedules Conference Call for Thursday, March 20, 2025 Schedules Conference Call for Thursday, March 20, 2025…

Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., March 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

MRVI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, March 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman

SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Maravai LifeSciences…

Maravai LifeSciences Holdings, Inc. Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against MRVI

Robbins LLP is Investigating Allegations that Maravai LifeSciences Holdings, Inc. (MRVI) Intentionally Recorded Unearned Revenues…

MARAVAI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Maravai LifeSciences Holdings, Inc. and Encourages Investors to Contact the Firm

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

Maravai LifeSciences schließt Übernahme des DNA- und RNA-Geschäfts von Officinae Bio ab

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen im Bereich der Biowissenschaften für Forscher…

Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall By Investing.com

Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall…

Maravai LifeSciences: Still Struggling To Find Its Footing

…

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript

…

Maravai LifeSciences plant die Übernahme des DNA- und RNA-Geschäfts von Officinae Bio und fördert damit die Unterstützung innovativer Nukleinsäureforschung

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen im Bereich der Biowissenschaften für Forscher…

dpa-AFX ProFeed